BANGKOK, April 8, 2026 /PRNewswire/ -- Researchers from the Faculty of Medicine at Chulalongkorn University have identified a native probiotic strain, Lactobacillus rhamnosus L34, that may help reduce inflammation and toxin buildup in patients with chronic kidney disease (CKD) before dialysis. The discovery highlights the growing role of microbiome-based therapies in managing chronic diseases and has led to the development of a Thai-made probiotic supplement tailored specifically for Thai patients.